BILLEV PHARMA ApS: Financial statements 2016
CVR: 81814813
Source: annual report 2016, Danish Business Authority
01/05/2015 – 30/04/2016
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK 2,007,612 compared with DKK 636,436 the year before. Equity in the 2016 report amounted to DKK 2,327,612. The solvency ratio was 50.7%.
- Profit/Loss
- DKK 2,007,612
- Equity
- DKK 2,327,612
- Total Assets
- DKK 4,587,394
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | 2 mio. | 2.3 mio. | - |
| 2015 | - | 9.7 mio. | 636 t. | 956 t. | - |
| 2014 | - | 9.7 mio. | 517 t. | 1.5 mio. | - |
| 2013 | - | 9.4 mio. | 728 t. | 2.4 mio. | - |
Find more companies like BILLEV PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of June 29, 2016, VAN ARKENS HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.
As of June 29, 2016, UL JENSEN HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.
About BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.